Pain during Medical termination of pregnancy
Conditions
Interventions
Trade Name: oxynorm
Product Name: oxynorm
Pharmaceutical Form: Solution for injection/infusion
Trade Name: oxanest
Product Name: Oxanest
Pharmaceutical Form: Solution for injection/infusion
Trade Na
Sponsors
HUS - Naistentautien ja synnytysten tulosyksikkö
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients choosing medical abortion, are first time pregnant ag are aged between 15 to 19years and 25 to 35 years. Attending the study is voluntary Are the trial subjects under 18? yes Number of subjects for this age range: 65 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 160 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: -Abortion is done based on foetal abnormality or threat of patient's own health - More than one fetus -Patient's serious illness (ASA 3 or more) -BMI >35 kg/m2 -Known allergy to one of the trial drugs -History of opioid abuse -Problems of understanding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Adequate analgesia is crucial in patients undergoing medical abortion. We compare in controlled randomized trial pain management via PCA (patient controller analgesia) to our standard pain management in patients undergoing medical termination of pregnancy with gestational age over 9 weeks. In short we compare different administration routes of oxycodon. We hope to recognize those patients who benefit from more intensive pain management and to create guideline so that all patients receive adequate analgesia in the future.;Secondary Objective: Experience of painful and traumatic abortion may affect patients' future plans for pregnancies and childbirth. In addition this may lead patient to choose surgical abortion in case of reapportion, which exposes patient to operative risks.;Primary end point(s): Pain management via PCA is more effective (pain VAS is lower) and patient's satisfaction is higher. Teen-aged women profit more on effective pain management than their adult controls.;Timepoint(s) of evaluation of this end point: Collecting data takes about 1,5-2 years and is done by the end of the year 2017. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Predicting factors of pain are patient's young age any longer duration of pregnancy.;Timepoint(s) of evaluation of this end point: Data is collected and ready to be evaluated in the end of the year 2017. | — |
Countries
Finland
Contacts
Public ContactHUS
HUS - Naistentautien ja synnytysten tulosyksikkö
Outcome results
None listed